| Dr Catherine A Gundlach, PHARMD | |
|
190 E Bannock St, Inpatient Pharmacy, Boise, ID 83712-6241 | |
| (208) 381-2476 | |
| (208) 381-3554 |
| Full Name | Dr Catherine A Gundlach |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 190 E Bannock St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023237583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | P5193 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Catherine A Gundlach, PHARMD 190 E Bannock St, Inpatient Pharmacy, Boise, ID 83712-6241 Ph: (208) 381-2476 | Dr Catherine A Gundlach, PHARMD 190 E Bannock St, Inpatient Pharmacy, Boise, ID 83712-6241 Ph: (208) 381-2476 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
Cancer Council is calling on partners of men with prostate cancer to reach out for support, with research showing partners experience high levels of distress related to the diagnosis of their loved one.
It seems improbable that a baby born underweight would be prone to obesity, but it is well documented that these children tend to put on weight in youth if they're allowed free access to calories. Now, researchers believe they understand why this happens.
Vaccines are an essential tool for preventing and treating serious infectious diseases such as polio, chicken pox and measles. But so far it has not been possible to develop vaccines capable of contributing to the treatment and prevention of chronic infectious diseases such as HIV and hepatitis C.
Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.
› Verified 6 days ago
Eleanor I Evans, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 Fax: 208-389-1458 | |
Ms. Fatima Walizada, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 | |
David Lyn Harrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9196 W Emerald St, Suite 110, Boise, ID 83704 Phone: 208-323-1259 Fax: 208-323-5666 | |
Mary Gobeille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 W Franklin Rd, Boise, ID 83705 Phone: 208-429-6433 | |
Megan B Seewald, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3233 N Cole Rd, Boise, ID 83704 Phone: 208-501-7032 Fax: 208-501-7026 | |
Dr. Christopher K Johnson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3232 Elder Street, Boise, ID 83705 Phone: 208-364-1829 Fax: 180-032-7554 | |
Dr. Catherine M Oliphant, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 E Jefferson St, Suite 201, Boise, ID 83712 Phone: 208-381-4146 Fax: 208-381-1665 |